Evidence map›Paper›PMID 29137372›Full record

ArticleOncotarget2017

microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma.

Ke Cao, Jingjing Li, Jia Chen, Li Qian, Aijun Wang, Xiang Chen, Wei Xiong, Jintian Tang, Shijie Tang, Yong Chen and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Metabolic Reprogramming in Melanoma: An Epigenetic Point of View.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The roles of glucose metabolic reprogramming in chemo- and radio-resistance.Journal of experimental & clinical cancer research : CR · 2019
    Review
  19. Article
  20. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Ke Cao *Department of Oncology of Third Xiangya Hospital, Central South University, Changsha, China.
Jingjing Li *Department of Plastic Surgery of Third Xiangya Hospital, Central South University, Changsha, China.
Jia Chen *Department of Plastic Surgery of Third Xiangya Hospital, Central South University, Changsha, China.
Li QianDepartment of Burn and Plastic Surgery of Second Xiangya Hospital, Central South University, Changsha, China.
Aijun WangSurgical Bioengineering Laboratory, Department of Surgery, UC Davis School of Medicine, Sacramento, California, USA.
Xiang ChenDepartment of Dermatology of Xiangya Hospital, Central South University, Changsha, China.
Wei XiongCancer Research Institute, Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, Changsha, China.
Jintian TangInstitute of Medical Physics and Engineering, Department of Engineering Physics, Tsinghua University, Beijing, China.
Shijie TangDepartment of Plastic Surgery, Second Hospital of Shantou University, Shantou, China.
Yong ChenKey Laboratory of Genetics and Birth Health of Hunan Province, Family Planning Institute of Hunan Province, Changsha, China.
Yao ChenDepartment of Plastic Surgery of Third Xiangya Hospital, Central South University, Changsha, China.
Yan ChengSchool of Pharmaceutical sciences, Central South University, Changsha, China.
Jianda ZhouDepartment of Plastic Surgery of Third Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNThird Xiangya Hospital · CNSecond Affiliated Hospital of Shantou University Medical College · CNSecond Xiangya Hospital of Central South University · CNTsinghua University · CNUniversity of California, Davis · USXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycolysis was reported to have a positive correlation with radioresistance. Our previous study found that the miR-33a functioned as a tumor suppressor in malignant melanoma by targeting hypoxia-inducible factor1-alpha (

Indexed as

glucoseHIF-1αlactate dehydrogenase AmicroRNAradiation

Identifiers

PMID29137372
PMCPMC5663544
OpenAlexW2730672846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.